Accessibility Menu
BioTech Medics logo

BioTech Medics(OTC) BMCS

Market Cap$20.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-100%
5 Year-100%
1 Year-99%
1 Month+0%
$0.00
+0.00%
+0.00Today
BioTech Medics last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-26
BioTech Medics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-90%USD 0.002026-07-29
1 month+0%USD 0.002026-07-27
3 month-66.67%USD 0.002026-05-22
Year to date-98.75%USD 0.012025-12-31
1 year-99.06%USD 0.012025-08-22
3 year-99.33%USD 0.022023-08-24
5 year-99.82%USD 0.062021-08-27
Since inception-100%USD 21.002004-12-07

BioTech Medics Financials at a Glance

Market Cap

$20.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$6.25K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

20.10 (High)

Price

$0.00

Volume

25,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

BMCS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioTech Medics

BioTech Medics, Inc. is a holding company focused on the medical field, managing therapeutic laser clinics that treat various pain conditions. The company also develops and markets nutraceutical products aimed at enhancing health and wellness.

Products and Services
  • Therapeutic laser clinics for pain management
  • SHBAN, an antiseptic sanitizing solution
  • BioBody Balance and BioBody Energy Spray nutritional supplements
Growth Outlook
  • Expansion of laser clinics across multiple states enhances market reach
  • Growing demand for non-invasive pain management solutions supports business growth
  • Increasing consumer interest in health supplements drives product sales
Financial Highlights
  • Recent quarterly net income of -$3,355 indicates ongoing operational challenges
  • Trailing twelve months show a price-to-earnings ratio of -69.32
  • Market capitalization stands at approximately $205,356
BioTech Medics, Inc. operates in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. The company has established a presence in Texas, California, New Mexico, and Florida through its therapeutic laser clinics, which provide effective treatment for various pain conditions. Additionally, the product line includes SHBAN, an antiseptic solution, and nutritional supplements designed to support overall health. The growth outlook for BioTech Medics appears promising, driven by the expansion of its clinic network and increasing consumer demand for non-invasive treatment options. The company's focus on nutraceuticals aligns with current health trends, potentially enhancing revenue streams. Financially, the company faces challenges, as indicated by the recent quarterly net income and a negative price-to-earnings ratio. However, the market capitalization reflects a stable position within the industry. Investors may find interest in the company's strategic direction and product offerings as it navigates the evolving healthcare landscape.
AI Generated • Aug 9, 2026

Industry

Healthcare Providers and Services

CEO

Anthony Keith Miller, MBA

Headquarters

Southlake, TX 76092-0114, US

BMCS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-0.00%

Return on Capital

-0.00%

Return on Assets

-0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

205.36M

Volume

25.00K

Avg. Volume

1.52K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$6.25K

EBITDA

$12.19K

Operating Cash Flow

$8.00

Capital Expenditure

-$7.00

Free Cash Flow

-$5.00

Cash & ST Invst.

-$302.00

Total Debt

$2.00K

BioTech Medics Performance Analysis

BioTech Medics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
BioTech Medics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q32024-09-30N/A
Q42024-12-31N/A
Q12025-03-31N/A
BioTech Medics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.00N/A
20222022-12-31USD -0.00-62.5%
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
BioTech Medics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30100.0%
Q32024-09-30N/A
Q42024-12-31250.0%
Q12025-03-31-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$20.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$3.36K

+73.2%

EBITDA

-$3.36K

+73.2%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

-$302.00

-102.8%

Total Debt

$2.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.00K

+0.0%

Return on Assets

-0.00%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

$52.11K

+333.7%

Operating Cash Flow

$52.11K

+333.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SRUTFSproutly Canada Inc.
$0.00+0.00%
EDXCEndexx Corporation
$0.00+0.00%
MJNAMedical Marijuana, Inc.
$0.00+0.00%
HBRMHerborium Group, Inc.
$0.00+9900.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$45.35-0.06%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$123.05+0.06%
NVDANvidia
$227.98+0.09%
IRENIren
$40.53+0.02%

Questions About BMCS

What is the current price of BioTech Medics?

BioTech Medics is trading at $0.00 per share.

What is the 52-week range for BioTech Medics?

Over the past 52 weeks, BioTech Medics has traded between $0.00 and $0.01.

How much debt does BioTech Medics have?

As of the most recent reporting period, BioTech Medics reported total debt of $2.00K.

How much cash does BioTech Medics have on hand?

BioTech Medics reported -$302.00 in cash and cash equivalents in its most recent financial results.

What is BioTech Medics’s dividend yield?

BioTech Medics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.